The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations
Alexandre, J.; Malheiro, R.; Dias da Silva, D.; Carmo, H.; Carvalho, F.; Silva, J.P. The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations. Int. J. Mol. Sci. 2020, 21, 6277. https://doi.org/10.3390/ijms21176277
Alexandre J, Malheiro R, Dias da Silva D, Carmo H, Carvalho F, Silva JP. The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations. International Journal of Molecular Sciences. 2020; 21(17):6277. https://doi.org/10.3390/ijms21176277
Chicago/Turabian StyleAlexandre, João; Malheiro, Rui; Dias da Silva, Diana; Carmo, Helena; Carvalho, Félix; Silva, João P. 2020. "The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB1 Receptor-Mediated Neuronal Differentiation at Biologically Relevant Concentrations" Int. J. Mol. Sci. 21, no. 17: 6277. https://doi.org/10.3390/ijms21176277